The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

Unique reproducibility effort in Brazil focuses on common methods rather than a single field ― and prompts call for reform.

The company is hoping longer follow-up will deliver enough positive trial data on its CRISPR T-cell therapies for blood ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...